Attached files
| file | filename |
|---|---|
| 10-K - 10-K - BIOLASE, INC | biol-10k_20161231.htm |
| EX-32.1 - EX-32.1 - BIOLASE, INC | biol-ex321_6.htm |
| EX-31.1 - EX-31.1 - BIOLASE, INC | biol-ex311_8.htm |
| EX-21.1 - EX-21.1 - BIOLASE, INC | biol-ex211_345.htm |
| EX-10.21 - EX-10.21 - BIOLASE, INC | biol-ex1021_618.htm |
| EX-10.20 - EX-10.20 - BIOLASE, INC | biol-ex1020_620.htm |
| EX-10.19 - EX-10.19 - BIOLASE, INC | biol-ex1019_621.htm |
| EX-10.18 - EX-10.18 - BIOLASE, INC | biol-ex1018_619.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
BIOLASE, Inc.
Irvine, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-194889, 333-144095, 333-112173, 333-130677, 333-177339, 333-204059, and 333-150105) and Form S-3 (Nos. 333-106260, 333-200623, 333-198291, 333-166145, 333-190158, 333-193426 and 333-214281) of BIOLASE, Inc. of our report dated March 10, 2017, relating to the consolidated financial statements and consolidated financial statement schedule of BIOLASE, Inc., appearing in this Annual Report on Form 10-K for the year ended December 31, 2016. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
Costa Mesa, California
March 10, 2017